Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APO-THEO LA TABLET 100 MG - HSA Drug Approval Details

Approvals/HSA/APO-THEO LA TABLET 100 MG

Approved

THERAPEUTIC

APO-THEO LA TABLET 100 MG

APOTEX INC (CANADA)🇸🇬 Health Sciences Authority

Approval Date: Oct 5, 1998
Approval ID: 095fcb7938e78f72
Company: APOTEX INC (CANADA)
Type: Therapeutic

Approval Details

Approval Id: 095fcb7938e78f72
Drug Name: APO-THEO LA TABLET 100 MG
Product Name: APO-THEO LA TABLET 100 MG
Approval Number: SIN10158P
Approval Date: 1998-10-05
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: R03DA04
Atc Item Name: theophylline
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD

Active Ingredients

THEOPHYLLINE

100 mg

THEOPHYLLINE

100 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 5, 1998

Approval ID

095fcb7938e78f72

Type

Therapeutic

Back to HSA Approvals